CroíValve
CroíValve develops the DUO™ System, a minimally invasive heart valve device designed to treat patients suffering from tricuspid regurgitation. The system functions by assisting the native tricuspid valve to restore normal function while preserving the heart's natural anatomy. The technology is currently under clinical investigation and targets the millions of patients in the US and Europe affected by this heart disease.
Healthtech
Medical Devices
Healthcare
Funding summary
- Total raised
- €11.2M
- Funding rounds
- 2
Investors in CroíValve
Investors on record for CroíValve. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like CroíValve?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors